JP2011173866A5 - - Google Patents

Download PDF

Info

Publication number
JP2011173866A5
JP2011173866A5 JP2011000720A JP2011000720A JP2011173866A5 JP 2011173866 A5 JP2011173866 A5 JP 2011173866A5 JP 2011000720 A JP2011000720 A JP 2011000720A JP 2011000720 A JP2011000720 A JP 2011000720A JP 2011173866 A5 JP2011173866 A5 JP 2011173866A5
Authority
JP
Japan
Prior art keywords
acid
carboxyphenoxy
bis
formulation
butylidenephthalide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011000720A
Other languages
English (en)
Japanese (ja)
Other versions
JP5727236B2 (ja
JP2011173866A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011173866A publication Critical patent/JP2011173866A/ja
Publication of JP2011173866A5 publication Critical patent/JP2011173866A5/ja
Application granted granted Critical
Publication of JP5727236B2 publication Critical patent/JP5727236B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011000720A 2010-01-05 2011-01-05 抗がん製剤 Active JP5727236B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29231110P 2010-01-05 2010-01-05
US61/292,311 2010-01-05

Publications (3)

Publication Number Publication Date
JP2011173866A JP2011173866A (ja) 2011-09-08
JP2011173866A5 true JP2011173866A5 (https=) 2013-12-19
JP5727236B2 JP5727236B2 (ja) 2015-06-03

Family

ID=43801814

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011000720A Active JP5727236B2 (ja) 2010-01-05 2011-01-05 抗がん製剤

Country Status (5)

Country Link
US (2) US20110165201A1 (https=)
EP (1) EP2343051B1 (https=)
JP (1) JP5727236B2 (https=)
DK (1) DK2343051T3 (https=)
ES (1) ES2522167T3 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI386203B (zh) * 2011-01-07 2013-02-21 Univ China Medical 治療腦癌或用以降低腦癌細胞對替莫唑胺之抗藥性之醫藥組合物及其應用
TWI472519B (zh) * 2011-12-20 2015-02-11 Nat Univ Dong Hwa 含正-亞丁基苯酞之醫藥組成物用於治療肝損傷及改善肝功能
US8927601B2 (en) 2011-12-20 2015-01-06 National Dong Hwa University Uses of N-butylidenephthalide in treating a liver injury and improving liver function
TWI522099B (zh) * 2014-06-04 2016-02-21 中國醫藥大學 治療胰臟癌之醫藥配方及其應用
TWI511727B (zh) 2014-07-02 2015-12-11 Everfront Biotech Inc 苯酞化合物之應用
PT3165222T (pt) * 2014-07-04 2020-05-14 Everfront Biotech Inc Utilização do composto de ftalida
CN112451519A (zh) * 2014-07-28 2021-03-09 长弘生物科技股份有限公司 丁烯基苯酞的用途及将其制备为医药组合物的方法
JP6371898B2 (ja) * 2014-07-28 2018-08-08 易珈生技股▲ふん▼有限公司 ブチリデンフタリドの用途、その使用方法及びそれを使用して医薬組成物を製造する方法
ES2850498T3 (es) * 2016-05-23 2021-08-30 Everfront Biotech Inc Uso de Z-butilidenftalida en la activación del sistema autoinmune
CN113425707B (zh) * 2021-07-30 2022-12-30 青岛大学附属医院 壬二酸预防蒽环类抗肿瘤药物心肌毒性的应用
IT202300013845A1 (it) * 2023-07-04 2025-01-04 Akeso S R L Composizione cosmetica contenente microsfere di chitosano e acido azelaico
IT202300013839A1 (it) * 2023-07-04 2025-01-04 Akeso S R L Composizione cosmetica contenente microsfere di chitosano e acido azelaico funzionalizzate con olio ozonizzato

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626862A (en) * 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
US6297337B1 (en) 1999-05-19 2001-10-02 Pmd Holdings Corp. Bioadhesive polymer compositions
DE60335608D1 (de) 2002-02-27 2011-02-17 Pharmain Corp Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
GB0318682D0 (en) 2003-08-08 2003-09-10 Novartis Ag Organic compounds
US20050255060A1 (en) * 2004-05-10 2005-11-17 Oblong John E Personal care compositions and methods regulating mammalian hair growth
TWI298259B (en) * 2004-10-08 2008-07-01 Tzu Chi Buddhist General Hospital Pharmaceutical composition for inhibiting/treating brain cancer
CA2615200A1 (en) * 2008-01-03 2009-07-03 National Research Council Canada Use of alkylphthalides for inducing phase 2 proteins

Similar Documents

Publication Publication Date Title
JP2011173866A5 (https=)
Zhang et al. Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates
JP2016510019A5 (https=)
JP2016512248A5 (https=)
JP2012533546A5 (https=)
JP2013213217A5 (https=)
JP2017504611A5 (https=)
HK1203149A1 (en) Novel dosage form and formulation of abediterol
JP2013527232A5 (https=)
JP2012012418A5 (https=)
WO2009112273A3 (en) Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
JP2014515039A5 (https=)
HK1201475A1 (en) Methods and compositions for treating pain
WO2012101639A3 (en) Nanoparticles based for dermal and systemic delivery of drugs
AU2013373885B2 (en) Oxazolidone compound, preparing method and application thereof
WO2012104275A3 (en) Nanoparticles delivery systems, preparation and uses thereof
JP2017514800A5 (https=)
JP2012126725A5 (https=)
JP2013542205A5 (https=)
WO2016012418A3 (de) Deodorantzubereitungen umfassend polyquaternium-16-polymere
JP2016511747A5 (https=)
JP2016529286A5 (https=)
JP2016526021A5 (https=)
JP2013533867A5 (https=)
HK1203050A1 (en) Novel dosage and formulation